Zhengyuan capsules for the treatment of chemotherapy-induced cancer-related fatigue in stage IIIB-IV unresectable NSCLC: study protocol for a randomized, multi-center, double-blind, placebo-controlled clinical trial.

Lin, Jietao; Yang, Ting; Chen, Wenmin; Qi, Xiangjun; Cao, Yang; Zheng, Xinting; Chen, Hanrui; Sun, Lingling; Lin, Lizhu

Lin, Jietao; Yang, Ting; Chen, Wenmin; Qi, Xiangjun; Cao, Yang; Zheng, Xinting; Chen, Hanrui; Sun, Lingling; Lin, Lizhu.

Afiliación

Lin J; Oncology Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Yang T; Guangzhou University of Chinese Medicine, Guangzhou, China.
Chen W; Guangzhou University of Chinese Medicine, Guangzhou, China.
Qi X; Guangzhou University of Chinese Medicine, Guangzhou, China.
Cao Y; Oncology Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Zheng X; Oncology Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Chen H; Oncology Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Sun L; Oncology Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Lin L; Oncology Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.

J Thorac Dis ; 14(11): 4560-4570, 2022 Nov.

Article en En | MEDLINE | ID: mdl-36524089

Palabras clave

Cancer-related fatigue (CRF); Zhengyuan capsule; chemotherapy; non-small cell lung cancer (NSCLC); traditional Chinese medicine (TCM)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: J Thorac Dis Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google